亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

深圳石金谷科技有限公司  

化學合成原料藥、醫藥中間體、化工原料、香精香料、食品輔料、植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:劉艷平
  • 電話:0755-61930350
  • 郵件:sz09@yccreate.com
  • 傳真:0755-84556470
  • QQ:2355880511
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 禁發 鹽酸氨溴索原料廠家供應信息,價格,用途
禁發 鹽酸氨溴索原料廠家供應信息,價格,用途
單價 面議對比
詢價 暫無
發貨 廣東深圳市付款后3天內
品牌 南箭
型號 23828-92-4
規格 醫藥級
過期 長期有效
更新 2013-08-13 11:01
 
詳細信息

禁發 鹽酸氨溴索原料廠家供應信息,價格,用途
禁發 鹽酸氨溴索
別名:菼清
英文名:Ambroxol Hydrochloride and Ge Injection
漢語拼音:Yansuan Anxiusuo Putaotang Zhusheye
本品主要成份為禁發 鹽酸氨溴索,其化學名稱為反式-4-[(2-氨基3.5-二溴芐基)氨基]環已醇出現被限制詞語
其結構式為: BrBrCH2NHNH2OH·HCl
CAS: 23828-92-4
分子式:C13H18Br2N2O·HCL
分子量:414.57
性狀
無色澄明液體
禁發 鹽酸氨溴索,分子式為C13H18Br2N2O·HCL,無色澄明液體。它可促進呼吸道內部粘稠分泌物的排除及減少粘液的滯留,因而顯著促進排痰。適用于伴有痰液分泌不正常及排痰功能不良的急性、慢性呼吸系統疾病


 

©2025 深圳石金谷科技有限公司 版權所有   技術支持:化工網   訪問量:28624  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |